Advertisement
UK markets closed
  • FTSE 100

    7,877.05
    +29.06 (+0.37%)
     
  • FTSE 250

    19,450.67
    +110.53 (+0.57%)
     
  • AIM

    744.99
    +1.87 (+0.25%)
     
  • GBP/EUR

    1.1692
    +0.0025 (+0.21%)
     
  • GBP/USD

    1.2465
    +0.0009 (+0.07%)
     
  • Bitcoin GBP

    50,953.39
    +2,520.01 (+5.20%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • S&P 500

    5,046.60
    +24.39 (+0.49%)
     
  • DOW

    37,987.98
    +234.67 (+0.62%)
     
  • CRUDE OIL

    82.61
    -0.08 (-0.10%)
     
  • GOLD FUTURES

    2,398.10
    +9.70 (+0.41%)
     
  • NIKKEI 225

    38,079.70
    +117.90 (+0.31%)
     
  • HANG SENG

    16,385.87
    +134.03 (+0.82%)
     
  • DAX

    17,837.40
    +67.38 (+0.38%)
     
  • CAC 40

    8,023.26
    +41.75 (+0.52%)
     

Startup Battlefield Disrupt 2021 - Cellino

Cellino is on a mission to make personalized, autologous cell therapies accessible for patients. Stem cell-derived regenerative medicines will cure some of the toughest diseases within this decade, including Parkinson’s, diabetes, and heart disease. Patient-specific cells provide the safest, most effective cures. Cellino’s platform uses AI-guided lasers to make personalized regenerative medicines at scale for the first time.